Skip to Main content Skip to Navigation
Journal articles

Preclinical assessment of scleral lens as a reservoir-based ocular therapeutic system

Abstract : Purpose - Bacterial keratitis is a sight threatening infection of the cornea which remains one of the most important potential complications of contact lens use. If the corneal ulcer is small, peripheral with no impending perforation present, intensive monotherapy with fluoroquinolones could be used. Therefore, a study was conducted with the objective to provide pharmacological data of the intra-ocular diffusion after administration of Ofloxacin using a scleral lens reservoir, as well as an evaluation of surface tolerability in rabbits. Materials and methods - Samples of corneas, aqueous humor and vitreous were collected to measure the drug levels of Ofloxacin using High Performance Liquid Chromatography. The corneas were examined by electron microscopy scanning and the eyeballs by light polarizing microscopy in order to evaluate surface tolerability. Results - Ofloxacin levels found in the aqueous humor and cornea were higher than those previously reported. The mean Ofloxacin corneal levels exceeded the MIC (Minimum Inhibitory Concentration) for which 90% of isolates are indicated for all bacteria implicated in keratitis. Conclusion - To our knowledge, this is the first preclinical study assessing local tolerance and intra-ocular diffusion of Ofloxacin after administration using a scleral lens reservoir.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02454698
Contributor : Florian Lemaitre <>
Submitted on : Friday, January 24, 2020 - 4:58:39 PM
Last modification on : Wednesday, August 19, 2020 - 11:18:00 AM

Identifiers

Citation

Renaud Laballe, Jonathan Vigne, Eric Denion, Florian Lemaitre, Didier Goux, et al.. Preclinical assessment of scleral lens as a reservoir-based ocular therapeutic system. Contact Lens and Anterior Eye, Elsevier, 2016, 39 (5), pp.394-396. ⟨10.1016/j.clae.2016.04.008⟩. ⟨hal-02454698⟩

Share

Metrics

Record views

120